Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using platelet-rich plasma to treat parosmia

Official title: Randomized Clinical Trial of Intranasal Injection of Platelet-Rich Plasma for Treatment of Parosmia

Run by Stanford University · NCT06283745 · Data updated 2026-11-12

This study is testing whether injections of platelet-rich plasma can help people with parosmia, a condition that causes distorted smells, feel better after having upper respiratory infections.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorStanford University
Academic / other
Locations1 site (Palo Alto, California)
StatusRecruiting
StartedNovember 23, 2024
Main results expectedMarch 22, 2027
Study endsMarch 22, 2027
Registry record updatedNovember 22, 2024
Trial IDNCT06283745 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with parosmia resulting from upper respiratory infections and who have been experiencing symptoms for at least 6 months but less than 24 months.

Probably not a fit

Patients with olfactory loss due to trauma, chronic sinusitis, structural abnormalities, or neurodegenerative diseases are unlikely to benefit from this treatment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of intranasal injections of platelet-rich plasma (PRP) in treating parosmia, a condition characterized by distorted smell. PRP, derived from the patient's own blood, is known for its anti-inflammatory and regenerative properties. The study will involve patients who have experienced olfactory distortion due to upper respiratory infections and will assess improvements in their olfactory function. Participants will also engage in concurrent olfactory training as part of the standard care.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the quality of life for patients suffering from parosmia by restoring their sense of smell.

How similar studies have gone: Previous studies have shown safety and efficacy of PRP in treating olfactory loss, indicating potential for success in this novel application for parosmia.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients \>= 18 years of age
* Patients who have qualitative olfactory distortion
* Etiology of qualitative olfactory distortion is due to upper respiratory infection
* Quantitative score under the 10th percentile on the SSParoT (HedRang and HedDir)
* Quantitative score ≥ 8 on the QOD.
* At least 6 months of parosmia but less than 24 months
* Patients can have been previously treated with oral and topical steroids but this is not a requirement
* Patients will receive concurrent olfactory training - the practice of smelling strong odors (standard of care)
* Be able to read and understand English
* Be able and willing to provide Informed Consent

Exclusion Criteria:

* Patients \< 18 years of age, pregnant females, patients who have structural abnormalities on nasal endoscopy or radiographic imaging that would prevent injection into the olfactory cleft
* Olfactory loss due to trauma, chronic sinusitis / inflammation / polyps, neoplasms, or neurodegenerative diseases or patients who have had olfactory loss \> 24 months
* Patients with bleeding disorders or on blood thinners such as coumadin and plavix

Where it's running

  • Stanford Sinus Center / Stanford University School of Medicine
    Palo Alto, California, United States
    Recruiting

Study contacts

  • Principal investigator: Zara Patel, MD — Stanford Otolaryngology - Head and Neck Surgery
  • Study coordinator: Homer Abaya, BS
  • Email: habaya@stanford.edu
  • Phone: (650) 725-6500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • A digital tool to help decide about an ICD

    We’re testing a patient-friendly online aid to help people with advanced heart failure decide whether an implantable cardioverter-defibrillator (ICD) is right for them.

    Recruiting at 2 sites Stanford University · San Francisco, California and 1 other locations · NCT07913204

  • Wise Interventions to Boost Pediatric Weight Control

    This study tests whether adding two quick social-psychology activities (growth mindset and self-affirmation) to a family-based weight management program helps 10–15 year-olds with obesity achieve better BMI outcomes over 12 months.

    Recruiting Stanford University · Stanford, California · NCT07839832

  • Reducing Chronic Pain After Cesarean Delivery

    A single-session pain-relief class called Empowered Relief is tested alongside standard postpartum care to see if it helps women who have ongoing pain after cesarean delivery.

    Recruiting Stanford University · Palo Alto, California · NCT07799883

  • Human-created animated art vs AI-created art: does it change how you feel right away?

    This online trial tests whether watching a human-made animated art film or an AI-made one, or doing nothing, quickly changes mood or sense of connection in U.S. adults.

    Recruiting Stanford University · Palo Alto, California and 1 other locations · NCT07740148

  • SMILE in one eye vs Ray tracing-guided LASIK in the fellow eye

    This study tests two laser vision correction methods—SMILE in one eye and ray-tracing guided LASIK in the other eye—to see which provides better vision and quality of life for adults with myopia and astigmatism.

    Recruiting Phase 4 Stanford University · Palo Alto, California · NCT07721714

  • Voices Illuminating Solutions for Outdoor Workers’ Needs and Safety

    This trial tests whether adding bilingual Our Voice photovoice participation to standard bilingual occupational health education helps outdoor workers in California better address climate-related health risks.

    Recruiting Stanford University · Stanford, California · NCT07713264

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.